Literature DB >> 28425756

CNS hemangioblastomatosis in a patient without von Hippel-Lindau disease.

Arie Franco1, Peter Pytel2, Rimas V Lukas3, Rupa Chennamaneni4, John M Collins1.   

Abstract

We report on a case of disseminated CNS hemangioblastoma, also referred to as hemangioblastomatosis, involving the supratentorial compartment and the entire spine. The patient presented with new onset headache, gait difficulties and memory deficits many years following resection of a hemangioblastoma from the cerebellum. The patient's family history was negative for von Hippel-Lindau (VHL) disease, and his personal history was negative for any additional VHL-defining lesions. Imaging revealed extensive dural caking and nodularity both supratentorially and in the spine, along with scattered parenchymal tumors showing a more typical appearance for hemangioblastoma. Biopsy of the dural thickening revealed histologic features compatible with hemangioblastoma. Genetic testing for VHL was eventually completed, and no evidence of a germline VHL mutation was detected.

Entities:  

Keywords:  VHL; disseminated hemangioblastoma; hemangioblastoma; hemangioblastomatosis; von Hippel–Lindau

Mesh:

Substances:

Year:  2017        PMID: 28425756      PMCID: PMC6020872          DOI: 10.2217/cns-2016-0027

Source DB:  PubMed          Journal:  CNS Oncol        ISSN: 2045-0907


  26 in total

1.  Hemangioblastoma without von Hippel-Lindau disease.

Authors:  Cara Innus; Joel Patterson
Journal:  JAAPA       Date:  2007-11

2.  Hemangioblastomas of the central nervous system. A 10-year study with special reference to von Hippel-Lindau syndrome.

Authors:  H P Neumann; H R Eggert; K Weigel; H Friedburg; O D Wiestler; P Schollmeyer
Journal:  J Neurosurg       Date:  1989-01       Impact factor: 5.115

3.  Malignant spread of haemangioblastoma: report on two cases.

Authors:  J Mohan; B Brownell; D R Oppenheimer
Journal:  J Neurol Neurosurg Psychiatry       Date:  1976-06       Impact factor: 10.154

4.  Von Hippel-Lindau disease manifesting disseminated leptomeningeal hemangioblastomatosis: surgery or medication?

Authors:  Qiao Zhang; Lu Ma; Wen-yan Li; Jing Chen; Yan Ju; Xu-hui Hui
Journal:  Acta Neurochir (Wien)       Date:  2010-10-13       Impact factor: 2.216

5.  Clinical features and natural history of von Hippel-Lindau disease.

Authors:  E R Maher; J R Yates; R Harries; C Benjamin; R Harris; A T Moore; M A Ferguson-Smith
Journal:  Q J Med       Date:  1990-11

6.  Statistical analysis of the two stage mutation model in von Hippel-Lindau disease, and in sporadic cerebellar haemangioblastoma and renal cell carcinoma.

Authors:  E R Maher; J R Yates; M A Ferguson-Smith
Journal:  J Med Genet       Date:  1990-05       Impact factor: 6.318

7.  The natural history of hemangioblastomas of the central nervous system in patients with von Hippel-Lindau disease.

Authors:  John E Wanebo; Russell R Lonser; Gladys M Glenn; Edward H Oldfield
Journal:  J Neurosurg       Date:  2003-01       Impact factor: 5.115

Review 8.  von Hippel-Lindau disease.

Authors:  Russell R Lonser; Gladys M Glenn; McClellan Walther; Emily Y Chew; Steven K Libutti; W Marston Linehan; Edward H Oldfield
Journal:  Lancet       Date:  2003-06-14       Impact factor: 79.321

9.  Hemangioblastomatosis in a patient with von Hippel-Lindau disease.

Authors:  M C J Hanse; A Vincent; M J van den Bent
Journal:  J Neurooncol       Date:  2007-01-26       Impact factor: 4.130

10.  Disseminated cerebellar hemangioblastoma in two patients without von Hippel-Lindau disease.

Authors:  Jiro Akimoto; Hirokazu Fukuhara; Tomohiro Suda; Kenta Nagai; Ryo Hashimoto; Kohno Michihiro
Journal:  Surg Neurol Int       Date:  2014-10-07
View more
  1 in total

1.  Aggressive dissemination of central nervous system hemangioblastoma without association with von Hippel-Lindau disease: A case report and literature review.

Authors:  François Dantas; Jair Leopoldo Raso; Patrícia Salomé Gouvea Braga; Ricardo Vieira Botelho; Fernando Luiz Rolemberg Dantas
Journal:  Surg Neurol Int       Date:  2022-08-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.